Literature DB >> 4058574

Autoregulation of tubulin synthesis in enucleated cells.

J M Caron, A L Jones, L B Rall, M W Kirschner.   

Abstract

The effects on tubulin messenger RNA levels and tubulin protein synthesis of treating cells with microtubule-depolymerizing drugs or directly microinjecting cells with tubulin have suggested that non-polymerized tubulin depresses its own synthesis. The precise level of this control is unclear. It has been shown that enucleated cells, termed cytoplasts, retain many properties of the original cell, including maintenance of cell shape, pinocytic activity and locomotion as well as biosynthetic activities such as protein synthesis and replication of cytoplasmic viruses. Furthermore, cytoplasts retain most of the components of the cytoskeleton including the centrioles. If cytoplasmic activities alone are responsible for regulating tubulin biosynthesis, cytoplasts should contain the necessary components. To distinguish between regulation which would occur in the nucleus, that is, alterations in mRNA synthesis or modifications of the mRNA, from alterations in mRNA stability and/or translatability which would take place in the cytoplasm, we examined the autoregulation of tubulin synthesis in enucleated cells. Here, we report that enucleated mouse fibroblasts retain the ability to turn off tubulin protein synthesis in response to microtubule depolymerization, the reduction in tubulin synthesis being accompanied by a corresponding decrease in tubulin mRNA levels. Thus, transcription, processing and transport of tubulin mRNA from the nucleus are not likely to be the loci of regulation. Instead, tubulin must reduce, either directly or indirectly, the translatability of its own mRNA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4058574     DOI: 10.1038/317648a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  32 in total

1.  Tissue-specific and constitutive alpha-tubulin genes of Drosophila melanogaster code for structurally distinct proteins.

Authors:  W E Theurkauf; H Baum; J Bo; P C Wensink
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Physical evidence for cotranslational regulation of beta-tubulin mRNA degradation.

Authors:  N G Theodorakis; D W Cleveland
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

3.  The adenovirus type 5 i-leader open reading frame functions in cis to reduce the half-life of L1 mRNAs.

Authors:  P D Soloway; T Shenk
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Extracellular matrix controls tubulin monomer levels in hepatocytes by regulating protein turnover.

Authors:  D J Mooney; L K Hansen; R Langer; J P Vacanti; D E Ingber
Journal:  Mol Biol Cell       Date:  1994-12       Impact factor: 4.138

5.  The complete sequence of a frog alpha-tubulin gene and its regulated expression in mouse L-cells.

Authors:  D J Smith
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

Review 6.  Some thoughts on the partitioning of tubulin between monomer and polymer under conditions of dynamic instability.

Authors:  T J Mitchison; M W Kirschner
Journal:  Cell Biophys       Date:  1987-12

7.  Autoregulatory control of beta-tubulin mRNA stability is linked to translation elongation.

Authors:  D A Gay; S S Sisodia; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component.

Authors:  G Brewer; J Ross
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

9.  Stimulation of tubulin gene transcription by deciliation of sea urchin embryos.

Authors:  Z Y Gong; B P Brandhorst
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

10.  Role of luteal cell nucleus in the expression of gonadotropin action.

Authors:  P E Bibbins; C V Rao; F R Carman; N Chegini; Z M Lei
Journal:  J Endocrinol Invest       Date:  1991-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.